For many years, doctors have known that chronic infections can quietly damage the body over time.
One of these infections is hepatitis C, a virus that attacks the liver and can stay in the body for decades without clear symptoms. Around the world, millions of people live with hepatitis C and do not even know they have it.
Now, a new study from the Yale School of Medicine suggests that this hidden virus may also be linked to one of the deadliest forms of cancer: pancreatic cancer.
Pancreatic cancer is not as well known as breast or lung cancer, but it is one of the most dangerous. It is the third leading cause of cancer deaths in the United States. The pancreas is a small organ located deep in the abdomen, and it helps the body digest food and control blood sugar.
When cancer starts in the pancreas, it often grows silently and does not cause symptoms until it is already advanced. That is why most people are diagnosed very late, when treatment is much harder and survival rates are low.
In this new research, scientists looked at whether there is a link between chronic hepatitis C infection and pancreatic cancer. They used data from the Veterans Health Administration, which is one of the largest healthcare systems in the United States.
This gave them access to records from about 6.3 million people who had been tested for hepatitis C over many years. This large number of people helped the researchers find patterns that would be impossible to see in smaller studies.
The results showed that people who had chronic hepatitis C were about 1.8 times more likely to develop pancreatic cancer compared to people who tested negative for the virus.
To put this into perspective, common risk factors like diabetes or smoking only increased the risk by around 1.2 to 1.3 times. This means that chronic hepatitis C may be a stronger risk factor for pancreatic cancer than many people previously realized.
Even after taking into account other factors such as alcohol use, liver disease, and smoking habits, the link between hepatitis C and pancreatic cancer remained strong. This suggests that the virus itself may play a direct or indirect role in increasing cancer risk.
The researchers believe that long-term inflammation caused by the virus may damage tissues in the body, not only in the liver but also in nearby organs like the pancreas.
The study also found that even people who were exposed to hepatitis C but did not go on to develop a long-term infection had a slightly higher risk of pancreatic cancer.
This suggests that even a temporary exposure to the virus might leave lasting changes in the body. However, the risk was much higher in people who had a chronic infection that lasted for many years.
Another interesting finding was related to different genetic types of the virus. Hepatitis C comes in several forms, called genotypes. The researchers noticed that people with genotype 1 and genotype 3 had a slightly higher risk of pancreatic cancer compared to people with genotype 2.
Genotype 1 is the most common type in the United States. It is still not clear whether this difference is caused by the virus itself or by other hidden factors. More research will be needed to fully understand this part of the finding.
One of the most important messages of this study is the value of screening and treatment. Modern treatment for hepatitis C is much better than in the past. Today, doctors can use special antiviral medicines that are usually taken for eight to twelve weeks.
These medicines can cure about 95 percent of people who take them correctly. If hepatitis C can be found and treated early, this may lower the risk of developing serious problems later, including liver cancer and possibly pancreatic cancer as well.
At the Veterans Health Administration, more than 75 percent of patients have already been tested for hepatitis C. The researchers hope that this study will encourage more widespread testing in the general population.
Many people who were born between 1945 and 1965, as well as people with certain risk factors such as past drug use or unsafe medical procedures, may have been exposed without knowing it. A simple blood test can identify the infection and open the door to life-saving treatment.
The research team is also looking into how electronic health records could help doctors detect pancreatic cancer earlier. They are studying things like blood test results, body weight changes, and medication use to see if there are warning signs years before a diagnosis is usually made.
The goal is to create models that can identify people at high risk long before the disease becomes advanced. If these models are successful, doctors could monitor at-risk individuals more closely and catch cancer at an earlier, more treatable stage.
In reviewing and analyzing the findings of this study, it becomes clear that chronic hepatitis C may be an important but previously under-recognized risk factor for pancreatic cancer. The strength of this research lies in its very large sample size and long-term data, which make the results more reliable than many smaller studies.
However, it is also important to remember that most of the study population included veterans, who are mostly male. This means the results may not fully represent women or other groups in the general population. Even so, the strong connection between the virus and cancer risk cannot be ignored.
Overall, this research highlights the importance of early testing, treatment, and long-term monitoring for people exposed to hepatitis C. It also opens the door to new ideas about how viruses may contribute to cancer in parts of the body beyond the liver.
With better awareness, wider screening, and continued research, it may be possible to reduce the future burden of pancreatic cancer and save many lives.
If you care about liver health, please read studies that refined fiber is link to liver cancer, and the best and worst foods for liver health.
For more health information, please see recent studies about how to boost your liver naturally, and simple ways to detox your liver.
The study is published in JAMA Network Open.
Copyright © 2025 Knowridge Science Report. All rights reserved.
